Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
155.51
+1.29 (0.84%)
At close: Dec 5, 2025, 4:00 PM EST
156.50
+0.99 (0.64%)
After-hours: Dec 5, 2025, 6:57 PM EST
Neurocrine Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 15,505 | 13,820 | 12,946 | 11,482 | 8,080 | 8,955 | |
| Market Cap Growth | 30.20% | 6.75% | 12.75% | 42.11% | -9.78% | -9.54% | |
| Enterprise Value | 14,870 | 12,878 | 12,124 | 10,966 | 7,766 | 8,528 | |
| Last Close Price | 155.51 | 136.50 | 131.76 | 119.44 | 85.17 | 95.85 | |
| PE Ratio | 37.10 | 40.49 | 51.85 | 74.32 | 90.18 | 21.99 | |
| Forward PE | 17.39 | 18.15 | 21.34 | 22.53 | 24.55 | 22.30 | |
| PS Ratio | 5.76 | 5.87 | 6.86 | 7.71 | 7.13 | 8.56 | |
| PB Ratio | 5.16 | 5.34 | 5.80 | 6.72 | 5.88 | 7.95 | |
| P/TBV Ratio | 5.22 | 5.43 | 5.91 | 6.90 | 5.88 | 7.95 | |
| P/FCF Ratio | 26.14 | 24.80 | 35.80 | 35.56 | 34.66 | 41.15 | |
| P/OCF Ratio | 24.35 | 23.21 | 33.20 | 33.83 | 31.50 | 39.19 | |
| PEG Ratio | 1.14 | 0.31 | 0.65 | 0.66 | 0.37 | 0.37 | |
| EV/Sales Ratio | 5.54 | 5.47 | 6.43 | 7.37 | 6.85 | 8.15 | |
| EV/EBITDA Ratio | 26.09 | 21.11 | 29.14 | 41.44 | 35.51 | 25.37 | |
| EV/EBIT Ratio | 27.52 | 22.09 | 30.71 | 44.04 | 37.38 | 26.04 | |
| EV/FCF Ratio | 25.07 | 23.11 | 33.53 | 33.96 | 33.32 | 39.19 | |
| Debt / Equity Ratio | 0.16 | 0.19 | 0.19 | 0.15 | 0.32 | 0.37 | |
| Debt / EBITDA Ratio | 0.76 | 0.76 | 0.99 | 0.94 | 1.88 | 1.19 | |
| Debt / FCF Ratio | 0.81 | 0.89 | 1.19 | 0.81 | 1.89 | 1.90 | |
| Asset Turnover | 0.69 | 0.68 | 0.67 | 0.67 | 0.60 | 0.69 | |
| Inventory Turnover | 17.15 | 15.99 | 16.48 | 14.85 | 11.71 | 12.59 | |
| Quick Ratio | 2.89 | 3.06 | 2.25 | 2.49 | 3.65 | 5.14 | |
| Current Ratio | 3.38 | 3.40 | 2.45 | 2.70 | 3.96 | 5.45 | |
| Return on Equity (ROE) | 14.96% | 14.16% | 12.68% | 10.03% | 7.17% | 46.20% | |
| Return on Assets (ROA) | 8.66% | 10.46% | 8.78% | 7.01% | 6.82% | 13.46% | |
| Return on Capital (ROIC) | 10.41% | 12.68% | 10.66% | 8.22% | 7.75% | 15.33% | |
| Return on Capital Employed (ROCE) | 14.90% | 18.20% | 15.20% | 13.60% | 11.40% | 21.20% | |
| Earnings Yield | 2.76% | 2.47% | 1.93% | 1.35% | 1.11% | 4.55% | |
| FCF Yield | 3.83% | 4.03% | 2.79% | 2.81% | 2.89% | 2.43% | |
| Buyback Yield / Dilution | 1.30% | -2.67% | -2.12% | -1.02% | -0.10% | -2.19% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.